Looking at the stock we see that its previous close was $1.75 and the beta (5Y monthly) reads 1.412 with the day’s price range being $1.67 – $2.05. In terms of its 52-week price range, RGLS has a high of $2.91 and a low of $0.83. The company’s stock has gained about 38.89% over that past 30 days.
Regulus Therapeutics Inc has a market cap of $115.93 million and is expected to release its quarterly earnings report on 2025-Mar-12.
On the other hand, looking at the outlook for the RGLS stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Regulus Therapeutics Inc (RGLS) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 22.16% off its SMA20 and 33.65% from its 50-day simple moving average. The RSI (14) is pointing at 67.52 while the volatility over the past week is 22.06% and jumps to 11.89% over the past one month. The beta value is 1.02, while the average true range (ATR) is currently pointing at 0.18.
Coming back to Regulus Therapeutics Inc (NASDAQ:RGLS), we note that the average 3-month trading volume was 1.08 million, while that of the preceding 10-day period stands at 4.11 million. Current shares outstanding are 65.50 million.
The insiders hold 19.71% of the company’s shares while institutions hold 63.69%. The data shows that short shares as of 2025-03-14, stood at 2.04 million at a short ratio of 6.49. This represents a 390.00 short interest in shares outstanding on 2025-03-14. Shares short rose in March from the previous month at 2.03 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 10.76% up in year-to-date price movement.
